Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
WatchGuard Technologies is a global leader in unified cybersecurity, providing enterprise-grade security solutions designed for small to midsize organizations and managed service providers (MSPs). The company's product portfolio includes network security appliances, multi-factor authentication, advanced endpoint protection, and secure Wi-Fi solutions. Its flagship Unified Security Platform integrates these services into a single management interface, enabling simplified deployment and automated threat response. Headquartered in Seattle, WatchGuard serves over 250,000 customers worldwide and is recognized for its focus on making complex security accessible and manageable. The company is currently owned by Vector Capital and continues to innovate in areas like AI-driven threat detection and Secure Access Service Edge (SASE). While not a life sciences company itself, WatchGuard provides critical data protection and compliance infrastructure for healthcare and pharmaceutical organizations.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on WatchGuard Technologies.